Raleigh, North Carolina

Velocity Clinical Research at Raleigh Neurology

Velocity’s Neurology research site in Raleigh partners with Raleigh Neurology Associates, P.A., to conduct clinical trials related to disorders of the nervous system. Raleigh Neurology began conducting clinical trials in 1996 and later partnered with Meridian Clinical Research before being acquired by Velocity in 2022.

Through the partnership with Raleigh Neurology, the site is easily accessible to thousands of patients in the Research Triangle, including those established with the practice. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Raleigh team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Find a Study in Raleigh
Meet Our Raleigh Research Team

Velocity Clinical Research at Raleigh Neurology
1520 Sunday Drive, Suite 315, Raleigh, NC 27607

Phone: (984) 251-1336

Find a Clinical Trial in Raleigh
Use the dropdown to browse current studies in Raleigh.

Follow Velocity on Facebook for company updates and more.

Portrait Of Medical Team Standing Outside Hospital

About Velocity Clinical Research

treatment

200,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Clinical_Research_Careers-wide

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

clinical research team

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Use the Study Finder
Learn What to Expect When Joining a Study

Our experienced research team in Raleigh

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Raleigh is dedicated to conducting quality research in a professional and caring environment.

  • Leslie H. Boyce, MD

    Principal Investigator
    Dr. Boyce was born and raised in New Jersey. She graduated from Rutgers University with a BS in neurobiology and behavior, and she received an MD from the University of Medicine and Dentistry of New Jersey. Dr. Boyce completed a pediatrics and neurology training at Columbia Presbyterian Medical Center in New York City, and then spent a year there doing basic scientific research on cortical development. She moved to North Carolina with her family in 1996, and served as an Assistant Professor of Neurology, Division of Child Neurology, at the University of North Carolina at Chapel Hill from 1997 to 2009. In addition to board certification in pediatrics and neurology with special qualification in child neurology, Dr. Boyce became board certified in sleep medicine in 2007. 

  • Thomas Kirk, MD

    Principal Investigator
    Originally a native of Texas, Dr. Kirk received an Honors Program University Scholars BA degree from Baylor University, subsequently receiving his MD from the University of Texas Medical Branch and then completed his neurology residency at the Baylor College of Medicine in Houston. He fell in love with North Carolina while completing his sleep medicine fellowship with additional epilepsy training at Duke University Medical Center in 2010, making him one of the few board-certified and fellowship-trained sleep medicine specialists in the area.

    Dr. Kirk currently developed and serves as the Medical Director of the Raleigh Neurology Sleep Medicine Program in Durham and sees patients with any neurologic or sleep concern in both our Durham and Raleigh offices. He is board-certified in both neurology and sleep medicine and is a member of the American Academy of Neurology and American Academy of Sleep Medicine. Dr. Kirk keeps an informal, independent educational website for his patients at www.sleepneurology.com.

     

  • Timothy Ryan, MD

    Principal Investigator
    Born in Lake Forest, Illinois and raised in Annapolis, Maryland; Dr. Ryan graduated with a BS from the University of Notre Dame in 2013 and earned his MD from the University of Maryland School of Medicine in 2017. Dr. Ryan then completed his internal medicine internship at the Baltimore MedStar Health hospitals in 2018. From 2018-2021, Dr. Ryan completed  his neurology residency at the University of California, Los Angeles serving as chief resident.  Following residency, Dr. Ryan completed a clinical neurophysiology fellowship at Cedars-Sinai receiving additional training in the management of epilepsy and neuromuscular patients and performing intraoperative neuromonitoring. Dr. Ryan is board certified in neurology and specializes in clinical neurophysiology.

    Dr. Ryan is a member of the American Academy of Neurology. He enjoys running, hiking, reading, and spending time with his family.

     

  • Kenneth Carnes, MD, PhD

    Principal Investigator
    Board certified in neurology, Kenneth Carnes, MD, PhD received his undergraduate degree in neurobiology from Brown University, and earned a combined MD/PhD from Washington University in St. Louis. Dr. Carnes completed a residency in adult neurology at Washington University Medical Center and a fellowship in Stroke Rehabilitation and Electrodiagnostic Studies at Washington University. He also completed an internship in internal medicine at Barnes-Jewish Hospital in St. Louis.

  • Casey F. Jeffreys, MD

    Principal Investigator
    Board certified in neurology, Casey F. Jeffreys, MD received her Bachelor of Science in neural science at New York University and her MD from the University of North Carolina School of Medicine. Dr. Jeffreys completed an internal medicine internship, neurology residency, and fellowship training in multiple sclerosis and neuroimmunology at Duke University. Additionally, she completed a residency in neurology and a fellowship in epilepsy and sleep medicine at Duke University Medical Center.

  • Bradley Robottom, MD

    Principal Investigator
    Bradley Robottom, MD practices general neurology with special interests in clinical research and in the use of botulinum toxin (Botox®) for neurological disorders. Dr. Robottom earned an MD from the Medical University of South Carolina. Since then, he served on the faculty at the University Of Maryland School Of Medicine, and completed a movement disorders fellowship at the University Of Maryland School Of Medicine, receiving additional training in the management of Parkinson’s disease and tremor disorders there. He also completed an internal medicine internship and neurology residency at the University of Maryland Medical Systems and is a member of the American Academy of Neurology and the Movement Disorders Society.

  • John Scagnelli, MD

    Principal Investigator
    John Scagnelli, MD, specializes in Multiple Sclerosis and Adult Neurology. Dr. Scagnelli received his BS in Human Development from Cornell University and earned his MD from the University of Miami, Miller School of Medicine. He completed a National Multiple Sclerosis Society Fellowship to study the clinical care and research of patients with multiple sclerosis and related disorders at the University of Virginia, as well as a Neurology Residency at the University of Rochester, Strong Memorial Hospital. He is a member of the National MS Society and the American Academy of Neurology.

Learn More About Participating in a Clinical Trial

Liver Illustration with blog title, All About Liver Disease - Terminology, Early Detection, Symptoms and and Long Term Risk

All About Liver Disease

Liver disease is a growing concern across the globe, especially in the United States, where the prevalence of conditions like Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis … Read more

What is Informed Consent

What is Informed Consent?

Joining a clinical trial is an important decision. Most participants come to the clinic with questions about clinical trials and what joining one could mean. This is why every study … Read more

Clinical Trial Phases What Happens in Phase 1, 2, 3 and 4

Clinical Trial Phases: What Happens in Phase 1, 2, 3 and 4?

Clinical trials are research studies of medications, vaccines, medical devices, procedures, diagnostics (tests), and other health-related products. These studies involve participants (also known as patients, volunteers, or subjects) to determine … Read more

Maryann - research study participant testimonial

Participant Story: Maryann, a Research Study Participant at Velocity

What led you to participate in a research study? I saw a roadside poster near the university in my neighborhood [for a vaccine study] and called Velocity. My first experience … Read more

Visit the Learning Center

Complete the form to start your clinical trial journey in Raleigh

Why join a clinical trial?

  • Help advance medicine
  • Learn about potential new medicines in development
  • Get study-related medical exams at no cost
  • Receive compensation for participating (available amounts may differ for each study)

After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.

Health insurance is generally not needed to join a clinical trial.

Remember, there is never an obligation to join — we're here to help you make the best decision.

Submit your info

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

View This Facility on Velocity's Corporate Website
clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.

Find a Study